Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Postponement of Meeting

---
identifier: "/us/fr/E8-16814"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Postponement of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "E8-16814"
section_name: "Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Postponement of Meeting"
positive_law: false
currency: "2008-07-23"
last_updated: "2008-07-23"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E8-16814"
document_type: "notice"
publication_date: "2008-07-23"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "73 FR 42819"
fr_volume: 73
docket_ids:
  - "Docket No. FDA-2008-N-0038"
fr_action: "Notice."
---


#  Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Postponement of Meeting

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is postponing the meeting of the Peripheral and Central Nervous Drugs Advisory Committee scheduled for August 6 and 7, 2008. This meeting was announced in the *Federal Register* of July 8, 2008 (73 FR 39017). The postponement is due to difficulties in empanelling the necessary experts due to both scheduling conflicts and conflict-of-interest issues.

**FOR FURTHER INFORMATION CONTACT:**

Diem-Kieu Ngo, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail: *[email protected]* , or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512543. Please call the Information Line for up-to-date information on this meeting.

Dated: July 17, 2008.

Randall W. Lutter,

Deputy Commissioner for Policy.